InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Boctor Fady. Director active across 1 company, notably Petros Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been recorded. History available since 21 December 2023. The latest transaction was disclosed on 19 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations